The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updates from ICARIA-MM, a phase 3 study of isatuximab (Isa) plus pomalidomide and low-dose dexamethasone (Pd) versus Pd in relapsed and refractory multiple myeloma (RRMM).
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Aurore Perrot
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Sanofi; Takeda
 
Jesús F. San-Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Meral Beksac
Consulting or Advisory Role - Amgen (Inst); Celgene (Inst); Janssen-Cilag (Inst); Oncopeptides; Sanofi Pasteur (Inst); Takeda (Inst)
Speakers' Bureau - Amgen (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi Pasteur (Inst)
 
Ivan Spicka
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Fredrik Schjesvold
Honoraria - Abbvie; Amgen; Celgene; Janssen Research & Development; Novartis
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen Research & Development; Oncopeptides; Takeda
Research Funding - Amgen Astellas BioPharma; Janssen Research & Development
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
 
Jeffrey SY. Huang
Research Funding - Sanofi
 
Jiri Minarik
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi
 
Michele Cavo
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
H. Miles Prince
Honoraria - Amgen; Celgene; Janssen Research & Development; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen Research & Development; Novartis; Takeda
Research Funding - Sanofi; Takeda
 
Cheng Zheng
Employment - Sanofi
 
Franck Dubin
Employment - Sanofi
 
Helgi Van De Velde
Employment - Sanofi
 
Kenneth Carl Anderson
Stock and Other Ownership Interests - C4 Therapeutics; OncoPep
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen Oncology; Millennium; Precision Biosciences; Sanofi; Tolero Pharmaceuticals
Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep